B. Yousefi, “Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells”, Cell Mol Biol (Noisy-le-grand), vol. 61, no. 8, pp. 118–122, Dec. 2015.